The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dang, H.
Right arrow Articles by Talal, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dang, H.
Right arrow Articles by Talal, N.

The Journal of Immunology, Vol 155, Issue 6 3205-3212, Copyright © 1995 by American Association of Immunologists

ARTICLES

SLE-like autoantibodies and Sjogren's syndrome-like lymphoproliferation in TGF-beta knockout mice

H Dang, AG Geiser, JJ Letterio, T Nakabayashi, L Kong, G Fernandes and N Talal
Audie L. Murphy Memorial Veterans Hospital, San Antonio, Texas, USA.

Mice bearing the TGF-beta 1 null mutation (-/-) develop lymphoid infiltrates in the heart, lungs, salivary glands, and other organs similar to those seen in the pseudolymphoma of Sjogren's Syndrome. We studied sera from -/- mice and found elevated Ab levels to dsDNA, ssDNA, and Sm ribonucleoprotein. No Abs to SSA/Ro or SSB/La and no IgM rheumatoid factor were found. Serum autoantibodies were predominately IgG and were specific as shown by ELISA inhibition studies. Antinuclear Ab patterns on Western blots varied from one mouse to the next, indicating a random process responsible for the diversity. Wild-type and heterozygote mice had no autoantibodies. Ig glomerular deposits were found in -/- mice, indicating that these autoantibodies may be pathogenic. Treatment of -/- mice with dexamethasone or TGF-beta 1 failed to suppress autoantibody production. These mice represent an overlap combining the autoimmune serology of SLE with the tissue infiltrates of SS. Our results support the concept that TGF-beta 1 is an important naturally occurring immunosuppressive cytokine whose absence can lead to a systemic autoimmune disease.


This article has been cited by other articles:


Home page
 Am. J. Pathol.Home page
A. Vitsky, J. Waire, R. Pawliuk, A. Bond, D. Matthews, E. LaCasse, M. L. Hawes, C. Nelson, S. Richards, P. A. Piepenhagen, et al.
Homeostatic Role of Transforming Growth Factor-{beta} in the Oral Cavity and Esophagus of Mice and Its Expression by Mast Cells in These Tissues
Am. J. Pathol., June 1, 2009; 174(6): 2137 - 2149.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. Wu, D. S. Melichian, E. Chang, M. Warner-Blankenship, A. K. Ghosh, and J. Varga
Rosiglitazone Abrogates Bleomycin-Induced Scleroderma and Blocks Profibrotic Responses Through Peroxisome Proliferator-Activated Receptor-{gamma}
Am. J. Pathol., February 1, 2009; 174(2): 519 - 533.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
V. Saxena, D. W. Lienesch, M. Zhou, R. Bommireddy, M. Azhar, T. Doetschman, and R. R. Singh
Dual Roles of Immunoregulatory Cytokine TGF-{beta} in the Pathogenesis of Autoimmunity-Mediated Organ Damage
J. Immunol., February 1, 2008; 180(3): 1903 - 1912.
[Abstract] [Full Text] [PDF]

Home page
 CROBMHome page
S.S. Prime, M. Pring, M. Davies, and I.C. Paterson
TGF-{beta} SIGNAL TRANSDUCTION IN ORO-FACIAL HEALTH AND NON-MALIGNANT DISEASE (PART I)
Critical Reviews in Oral Biology & Medicine, November 1, 2004; 15(6): 324 - 336.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Mamura, W. Lee, T. J. Sullivan, A. Felici, A. L. Sowers, J. P. Allison, and J. J. Letterio
CD28 disruption exacerbates inflammation in Tgf-{beta}1-/- mice: in vivo suppression by CD4+CD25+ regulatory T cells independent of autocrine TGF-{beta}1
Blood, June 15, 2004; 103(12): 4594 - 4601.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
A. Rosendahl, M. Speletas, K. Leandersson, F. Ivars, and P. Sideras
Transforming growth factor-{beta}- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis
Int. Immunol., December 1, 2003; 15(12): 1401 - 1414.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
Z.-m. Chen, M. J. O'Shaughnessy, I. Gramaglia, A. Panoskaltsis-Mortari, W. J. Murphy, S. Narula, M. G. Roncarolo, and B. R. Blazar
IL-10 and TGF-{beta} induce alloreactive CD4+CD25- T cells to acquire regulatory cell function
Blood, June 15, 2003; 101(12): 5076 - 5083.
[Abstract] [Full Text] [PDF]

Home page
 CROBMHome page
T. Thyagarajan, S. Totey, M. J. S. Danton, and A. B. Kulkarni
GENETICALLY ALTERED MOUSE MODELS: THE GOOD, THE BAD, AND THE UGLY
Critical Reviews in Oral Biology & Medicine, May 1, 2003; 14(3): 154 - 174.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
H Schotte, P Willeke, S Rust, G Assmann, W Domschke, M Gaubitz, and B Schluter
The transforming growth factor-{beta}1 gene polymorphism (G915C) is not associated with systemic lupus erythematosus
Lupus, February 1, 2003; 12(2): 86 - 92.
[Abstract] [PDF]

Home page
 Clin Med ResHome page
K. C. Flanders and J. K. Burmester
Medical Applications of Transforming Growth Factor-{beta}
Clin. Med. Res., January 1, 2003; 1(1): 13 - 20.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
S Lawman and M R Ehrenstein
Many paths lead to lupus
Lupus, December 1, 2002; 11(12): 801 - 806.
[PDF]

Home page
 Exp. Biol. Med.Home page
J. Cheng and J. P. Grande
Transforming Growth Factor-{beta} Signal Transduction and Progressive Renal Disease
Experimental Biology and Medicine, December 1, 2002; 227(11): 943 - 956.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
N. L. McCartney-Francis and S. M. Wahl
Dysregulation of IFN-{gamma} Signaling Pathways in the Absence of TGF-{beta}1
J. Immunol., November 15, 2002; 169(10): 5941 - 5947.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
C. A. Piccirillo, J. J. Letterio, A. M. Thornton, R. S. McHugh, M. Mamura, H. Mizuhara, and E. M. Shevach
CD4+CD25+ Regulatory T Cells Can Mediate Suppressor Function in the Absence of Transforming Growth Factor {beta}1 Production and Responsiveness
J. Exp. Med., July 15, 2002; 196(2): 237 - 246.
[Abstract] [Full Text] [PDF]

Home page
 CROBMHome page
P.B. Sugerman, N.W. Savage, L.J. Walsh, Z.Z. Zhao, X.J. Zhou, A. Khan, G.J. Seymour, and M. Bigby
THE PATHOGENESIS OF ORAL LICHEN PLANUS
Critical Reviews in Oral Biology & Medicine, July 1, 2002; 13(4): 350 - 365.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
A. Davidson and B. Diamond
Autoimmune Diseases
N. Engl. J. Med., August 2, 2001; 345(5): 340 - 350.
[Full Text] [PDF]

Home page
 JEMHome page
P. J. Lucas, S.-J. Kim, S. J. Melby, and R. E. Gress
Disruption of T Cell Homeostasis in Mice Expressing a T Cell-Specific Dominant Negative Transforming Growth Factor {beta} II Receptor
J. Exp. Med., April 3, 2000; 191(7): 1187 - 1196.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
H. D. Gresham, B. M. Dale, J. W. Potter, P. W. Chang, C. M. Vines, C. A. Lowell, C. F. Lagenaur, and C. L. Willman
Negative Regulation of Phagocytosis in Murine Macrophages by the Src Kinase Family Member, Fgr
J. Exp. Med., February 7, 2000; 191(3): 515 - 528.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
D. Grainger, D. Mosedale, J. Metcalfe, and E. Bottinger
Dietary fat and reduced levels of TGFbeta1 act synergistically to promote activation of the vascular endothelium and formation of lipid lesions
J. Cell Sci., January 7, 2000; 113(13): 2355 - 2361.
[Abstract] [PDF]

Home page
 Rheumatology (Oxford)Home page
M. L. Stoll and J. Gavalchin
Systemic lupus erythematosus--messages from experimental models
Rheumatology, January 1, 2000; 39(1): 18 - 27.
[Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Kobayashi, K. Yoshida, J. M. Ward, J. J. Letterio, G. Longenecker, L. Yaswen, B. Mittleman, E. Mozes, A. B. Roberts, S. Karlsson, et al.
{beta}2-Microglobulin-Deficient Background Ameliorates Lethal Phenotype of the TGF-{beta}1 Null Mouse
J. Immunol., October 1, 1999; 163(7): 4013 - 4019.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. L. Brown, S. Patil, C. D. Cianci, J. S. Morrow, and P. H. Howe
Transforming Growth Factor beta Induces Caspase 3-independent Cleavage of alpha II-Spectrin (alpha -Fodrin) Coincident with Apoptosis
J. Biol. Chem., August 13, 1999; 274(33): 23256 - 23262.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Mohan, Y. Yu, L. Morel, P. Yang, and E. K. Wakeland
Genetic Dissection of Sle Pathogenesis: Sle3 on Murine Chromosome 7 Impacts T Cell Activation, Differentiation, and Cell Death
J. Immunol., June 1, 1999; 162(11): 6492 - 6502.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
M. B. Datto, J. P. Frederick, L. Pan, A. J. Borton, Y. Zhuang, and X.-F. Wang
Targeted Disruption of Smad3 Reveals an Essential Role in Transforming Growth Factor beta -Mediated Signal Transduction
Mol. Cell. Biol., April 1, 1999; 19(4): 2495 - 2504.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
A N Theofilopoulos
Effector and predisposing genes in murine lupus
Lupus, November 1, 1998; 7(9): 575 - 584.
[Abstract] [PDF]

Home page
 LupusHome page
J P Grande
Mechanisms of progression of renal damage in lupus nephritis:Pathogenesis of renal scarring
Lupus, November 1, 1998; 7(9): 604 - 610.
[Abstract] [PDF]

Home page
 J. Immunol.Home page
K. Ohtsuka, J. D. Gray, M. M. Stimmler, B. Toro, and D. A. Horwitz
Decreased Production of TGF-{beta} by Lymphocytes from Patients with Systemic Lupus Erythematosus
J. Immunol., March 1, 1998; 160(5): 2539 - 2545.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
F. Bridoux, A. Badou, A. Saoudi, I. Bernard, E. Druet, R. Pasquier, P. Druet, and L. Pelletier
Transforming Growth Factor {beta} (TGF-{beta})-dependent Inhibition of T Helper Cell 2 (Th2)-induced Autoimmunity by Self-Major Histocompatibility Complex (MHC) Class II-specific, Regulatory CD4+ T Cell Lines
J. Exp. Med., May 19, 1997; 185(10): 1769 - 1775.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
F. Furukawa
Animal models of cutaneous lupus erythematosus and lupus erythematosus photosensitivity
Lupus, January 1, 1997; 6(2): 193 - 202.
[PDF]

Home page
 JEMHome page
T. A. Borkowski, J. J. Letterio, A. G. Farr, and M. C. Udey
A Role for Endogenous Transforming Growth Factor {beta}1 in Langerhans Cell Biology: The Skin of Transforming Growth Factor {beta}1 Null Mice Is Devoid of Epidermal Langerhans Cells
J. Exp. Med., December 1, 1996; 184(6): 2417 - 2422.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.